Schedules of Controlled Substances: Placement of Alfaxalone into Schedule IV
scheduling · Proposed Rule · Notice of proposed rulemaking. · Published 2013-03-25 · 78 FR 17895
Document
Document number
2013-06651
Federal Register citation
78 FR 17895
Type
Proposed Rule
Action
Notice of proposed rulemaking.
Category
scheduling
Publication date
2013-03-25
Abstract
The Drug Enforcement Administration (DEA) proposes the placement of 5[alpha]-pregnan-3[alpha]-ol-11,20-dione (alfaxalone) including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into Schedule IV of the Controlled Substances Act (CSA). This proposed action is pursuant to the CSA which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking.